{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:28:26Z","timestamp":1787761706020,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims:<\/jats:title>\n                    <jats:p>Vitiligo, an acquired sometimes familial depigmentary disorder of the skin and hair that results from selective destruction of melanocytes or pigment cells. It is the single most important non-neo plastic disease that involves both the immune system and melanocytes which are subsequently destroyed and the affected area turns pale and becomes white. The prevalence of the disease is between 1% and 2% in general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      It is a prospective, randomized, and controlled study. Over 90 vitiligo patients attending Dermatology OPD and vitiligo clinic are enrolled in the study. About 35 apparently healthy, age and sex matched individuals are selected to serve as control. A prescribed proforma containing all the demographic data, relevant questionnaire were recorded for each and every case with brief clinical history suggestive of any thyroid disease as well as those referred by the clinicians.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt;0.05 is considered significant. The Quantitative Determination of Thyroglobulin (Tg) Autoantibodies in Human Serum or Plasma by a Microplate Enzyme Immunoassay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Vitiligo group, thirty four (37.78%) patients have clinical hypothyroidism while 9 (10%) patients have clinical hyperthyroidism. This difference in the distribution is statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) with a Chi-square value of 10.08. The data are entered, analyzed and computed with SPSS version 15 software and well-known statistical test like Chi-square, students\u2019 \u2018t\u2019 test have been advocated wherever found applicable.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt;0.05 is considered significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>There is increased incidence of autoimmune thyroid diseases among vitiligo patients. The reason being vitiligo usually precedes the onset of thyroid dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_344_22","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T07:52:27Z","timestamp":1682495547000},"page":"619-624","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Study of thyroid disorders in vitiligo"],"prefix":"10.4103","volume":"12","author":[{"given":"Lalchamliani","family":"Khiangte","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Zoram Medical College, Falkawn, Mizoram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lalrindik","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Zoram Medical College, Falkawn, Mizoram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"228","DOI":"10.18231\/j.ijced.2021.043","article-title":"Knowledge, attitude and behaviour study of vitiligo among general population","volume":"7","author":"Kumar","year":"2021","journal-title":"IP Indian J Clin Exp Dermatol"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20260109","first-page":"641","article-title":"Lerner and Gisela Moeumam Vitiligo the immune connection in Dermatologic and Immunology and Allergy 1985","author":"Aaron"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.1985.tb01532.x","article-title":"The significance of vitiligo antibodies","volume":"12","author":"Brystyn","year":"1985","journal-title":"J Dermatol"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaad.2003.12.044","article-title":"Characteristics of genetic epidemiology and genetic models for vitiligo","volume":"51","author":"Zhang","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000081479","article-title":"Relevance of thyroiditis and other autoimmune diseases in children with vitiligo","volume":"210","author":"Lacovelli","year":"2005","journal-title":"Dermatology"},{"key":"R7-20260109","first-page":"68","article-title":"High frequency of thyroid dysfunction in Indian patients with vitiligo","volume":"48","author":"Shyria","year":"2003","journal-title":"Indian J Dermatol"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0738-081X(97)00128-4","article-title":"The epidemiology and genetics of vitiligo","volume":"15","author":"Norlund","year":"1997","journal-title":"Clin Dermatol"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archderm.1993.01680290066010","article-title":"Pattern of familial aggregation of vitiligo","volume":"129","author":"Majumder","year":"1993","journal-title":"Arch Dermatol"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0029-1211937","article-title":"Autoimmune thyroiditis in childhood epidemiology and laboratory findings","volume":"105","author":"Roth","year":"1994","journal-title":"Exp Clin Endo Diabetes"},{"key":"R11-20260109","first-page":"23","author":"Parker","year":"1981","journal-title":"Skin and Hormones Textbook of Endocrinology William RH WB Saunders Co Philadelphia"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-5793(85)80446-4","article-title":"Purification of the human thyroid and its identification as the microsomal antigen involved in the human thyroid disease","volume":"190","author":"Czarnoka","year":"1985","journal-title":"FEBS Lett"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1346-8138.1990.tb01607.x","article-title":"Radio-active iodine uptake in vitiligo","volume":"17","author":"Kumar","year":"1990","journal-title":"J Dermatol"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/08916930410001710857","article-title":"Autoantibodies as diagnostic and predictive markers of vitiligo","volume":"37","author":"Kemp","year":"2004","journal-title":"Autoimmunity"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Causatian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2003.257","article-title":"Autoimmune thyroid diseases Etiology pathogenesis and dermatological manifestations","volume":"48","author":"Ai","year":"2003","journal-title":"Am Acad Dermatol"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/0001555574124128","article-title":"High frequency of thyroid dysfunction in patients with vitiligo","volume":"74","author":"Hegedus","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community a twenty year follow-up of the Whickham survey","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R20-20260109","first-page":"3","article-title":"Anti-thyroid peroxidase antibody and vitiligo","volume":"6","author":"Maryam","year":"2007","journal-title":"BMC Dermatol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_344_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:03:43Z","timestamp":1787760223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_344_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_344_22","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-02-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}